Michaël Chassé

Michaël Chassé

Auto-generated profile, based on publicly available information

Michaël Chassé

Department of Medicine, Université de Montréal, Montreal, Canada

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
WBWilliam Beaubien‐Souligny
William Beaubien‐Souligny
ABAymen Benkreira
Aymen Benkreira
PRPierre Robillard
Pierre Robillard
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
MCMichaël Chassé
Michaël Chassé
ADAndré Denault
André Denault
Background: Acute kidney injury ( AKI ) after cardiac surgery is associated with adverse outcomes. Venous congestion can impair kidney function, but few tools are available to assess its impact at the bedside. The objective of this study was to determine whether portal flow pulsatility and alterations in intrarenal venous flow assessed by Point‐Of‐Care ultrasound are associated with AKI after cardiac surgery. Methods and Results: This single‐center prospective cohort study recruited patients undergoing cardiac surgery with cardiopulmonary bypass. Hepatic and renal Doppler ultrasound assessments were performed before surgery, at the intensive care unit admission, and daily for 3 days after surgery. The primary statistical analysis was performed using proportional hazards model for time‐dependent variables. Among the 145 patients included, 49 patients (33.8%) developed AKI after cardiac surgery. The detection of portal flow pulsatility was associated with an increased risk of AKI (hazard ratio: 2.09, confidence interval, 1.11–3.94, P=0.02), as were severe alterations of intrarenal venous flow (hazard ratio: 2.81, confidence interval, 1.42–5.56, P =0.003). These associations remained significant in multivariable models. The addition of these markers to preoperative risk factors and central venous pressure measurement at intensive care unit admission improved the prediction of AKI . (Continuous net reclassification improvement: 0.364, confidence interval, 0.081–0.652 for portal Doppler and net reclassification improvement: 0.343, confidence interval, 0.081–0.628 for intrarenal Doppler) Conclusions: Portal flow pulsatility and intrarenal flow alterations are markers of venous congestion and are independently associated with AKI after cardiac surgery. These tools might offer valuable information to develop strategies aimed at treating or preventing congestive cardiorenal syndrome after cardiac surgery. Clinical Trial Registration: URL : https://www.clinicaltrials.gov . Unique identifier: NCT 02831907.

26 November 2014 in JAMA
Verified
Journal Article
Closed access
PDF file
GKGreg A. Knoll
Greg A. Knoll
AHAtul Humar
Atul Humar
DFDean Fergusson
Dean Fergusson
OJOlwyn Johnston
Olwyn Johnston
AHAndrew A. House
Andrew A. House
JGJohn S. Gill
John S. Gill
Research from JAMA — Levofloxacin for BK Virus Prophylaxis Following Kidney Transplantation — A Randomized Clinical Trial

1 September 2016 in JAMA Internal Medicine
Verified
Journal Article
Closed access
PDF file
MCMichaël Chassé
Michaël Chassé
ATAlan Tinmouth
Alan Tinmouth
SEShane W. English
Shane W. English
JAJason P. Acker
Jason P. Acker
KWKumanan Wilson
Kumanan Wilson
DFDean A. Fergusson
Dean A. Fergusson
Research from JAMA Internal Medicine — Association of Blood Donor Age and Sex With Recipient Survival After Red Blood Cell Transfusion

1 April 2016 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
GKGreg A Knoll
Greg A Knoll
DFDean Fergusson
Dean Fergusson
MCMichaël Chassé
Michaël Chassé
PHPaul Hebert
Paul Hebert
GWGeorge Wells
George Wells
JGJohn Gill
John Gill

1 April 2016 in Transfusion Medicine Reviews
Verified
Journal Article
Open access
MCMichaël Chassé
Michaël Chassé
LMLauralyn McIntyre
Lauralyn McIntyre
SEShane W. English
Shane W. English
ATAlan Tinmouth
Alan Tinmouth
GKGreg Knoll
Greg Knoll
DFDean A. Fergusson
Dean A. Fergusson
Optimal selection of blood donors is critical for ensuring the safety of blood products. The current selection process is concerned principally with the safety of the blood donor at the time of donation and of the recipient at the time of transfusion. Recent evidence suggests that the characteristics of the donor may affect short- and long-term transfusion outcomes for the transfused recipient. We conducted a systematic review with the primary objective of assessing the association between blood donor characteristics and red blood cell (RBC) transfusion outcomes. We searched MEDLINE, EMBASE, and Cochrane Central databases and performed manual searches of top transfusion journals for all available prospective and retrospective studies. We described study characteristics, methodological quality, and risk of bias and provided study-level effect estimates and, when appropriate, pooled estimates with 95% confidence intervals using the Mantel-Haenszel or inverse variance approach. The overall quality of the evidence was graded using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. From 6121 citations identified by our literature search, 59 studies met our eligibility criteria (50 observational, 9 interventional). We identified the evaluation of association of 17 donor characteristics on RBC transfusion outcome. The risk of bias and confounding of the included studies was high. The quality of evidence was graded as very low to low for all 17 donor characteristics. Potential associations were observed for donor sex with reduced survival at 90 days and 6 months in male recipients that receive donated blood from females (hazard ratio 2.60 [1.09, 6.20] and hazard ratio 2.40 [1.10, 5.24], respectively; n = 1), Human Leukocyte Antigen - antigen D Related (HLA-DR) selected transfusions (odds ratio [OR] 0.39 [0.15, 0.99] for the risk of transplant alloimmunization, n = 9), presence of antileukocyte antibodies (OR 5.84 [1.66, 20.59] for risk of transfusion-related acute lung injury, n = 4), and donor RBC antigens selection (OR 0.20 [0.08, 0.52] for risk of alloimmunization, n = 4). Based on poor quality evidence, positive antileukocyte antibodies, female donor to male recipients, HLA-DR selected RBC transfusion, or donor RBC antigen selection may affect RBC transfusion outcome. Our findings that donor characteristics may be associated with transfusion outcomes warrant establishing vein-to-vein data infrastructure to allow for large robust evaluations. PROSPERO registration number: CRD42013006726.

26 November 2021 in Science Advances
Verified
Journal Article
Open access
EBElsa Brunet-Ratnasingham
Elsa Brunet-Ratnasingham
SASai Priya Anand
Sai Priya Anand
PGPierre Gantner
Pierre Gantner
ADAlina Dyachenko
Alina Dyachenko
GMGaël Moquin-Beaudry
Gaël Moquin-Beaudry
DKDaniel Kaufmann
Daniel Kaufmann
Statistical models of plasma immunovirological features validate SARS-CoV-2 vRNA as an early predictor of COVID-19 mortality.